Gardner Lewis Asset Management L P Cuts Holdings in Humana Inc. (NYSE:HUM)

Gardner Lewis Asset Management L P lessened its stake in Humana Inc. (NYSE:HUM - Free Report) by 56.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,670 shares of the insurance provider's stock after selling 12,445 shares during the period. Gardner Lewis Asset Management L P's holdings in Humana were worth $2,453,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. FPC Investment Advisory Inc. purchased a new position in Humana during the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC purchased a new position in Humana in the 4th quarter worth approximately $30,000. LFA Lugano Financial Advisors SA lifted its stake in Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana during the 4th quarter worth approximately $33,000. Finally, Atwood & Palmer Inc. grew its position in shares of Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 60 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Up 0.4 %

Shares of HUM traded up $0.96 during mid-day trading on Tuesday, reaching $265.56. The company's stock had a trading volume of 278,885 shares, compared to its average volume of 1,750,822. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The company's 50 day moving average is $269.77 and its 200 day moving average is $273.07. The stock has a market cap of $32.05 billion, a PE ratio of 26.68, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio (DPR) is presently 35.58%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HUM. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. JPMorgan Chase & Co. reduced their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Barclays raised their price target on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. Finally, StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Eighteen analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Humana currently has an average rating of "Hold" and an average price target of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.